BioXcel Therapeutics, Inc.
(NASDAQ: BTAI)

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

1.370

+0.060 (+4.58%)
Range 1.330 - 2.075   (56.02%)
Open 1.650
Previous Close 1.310
Bid Price 25.000
Bid Volume 10
Ask Price 27.000
Ask Volume 10
Volume 108,635,416
Value -
Remark
Delayed prices. Updated at 02 Aug 2025 04:00.
Data powered by
View All Events
Share your investing ideas
Please login to view stock data and analysis